#USA #Remote Patient Monitoring #Hoboken #Health Recovery Solutions #Rimidi

Health Recovery Solutions Expands Remote Care Programs through Rimidi Acquisition

Health Recovery Solutions (HRS), recognized as the leading remote patient monitoring enterprise in the nation, has announced its strategic acquisition of Rimidi, a distinguished company in chronic disease management. This move aims to enhance HRS's existing remote patient care capabilities by incorporating advanced tools designed to improve diabetes and cardiometabolic management.

Strengthening the Virtual Care Platform

HRS has firmly established itself as a frontrunner in remote patient care over the last decade, consistently acknowledged by industry analysts such as KLAS, Frost & Sullivan, and Newsweek. With a proven record of successful patient outcomes for over a million individuals and beneficial financial results for numerous healthcare organizations, HRS has positioned itself well in the healthcare market. The acquisition of Rimidi is a natural progression as HRS continues to expand into comprehensive care models, notably through its recently introduced PatientFirst Pathways initiative.

In response to the increasing demand for integrated chronic disease management, HRS's acquisition of Rimidi aligns with their mission to foster connected, data-driven patient care. The synergies expected from this merger will not only enhance HRS's capabilities but also offer innovative solutions to healthcare providers across the industry.

Addressing Key Healthcare Challenges

The partnership targets three significant challenges facing health systems today:
1. Scaling Remote Patient Monitoring (RPM): Healthcare organizations require a streamlined platform that can cater to various chronic conditions. By bringing Rimidi’s expertise in diabetes and cardiometabolic care into its ecosystem, HRS can provide seamless care coordination for a wider range of health issues while ensuring quality outcomes.

2. Enhancing Longitudinal Care Models: The unified forces of HRS and Rimidi facilitate an improved approach to continuous care, allowing for data-informed management from diagnosis through recovery and chronic disease maintenance. This not only benefits patients but alleviates the administrative burdens that stress healthcare providers.

3. Vendor Management Efficiency: The integration will simplify procurement and support processes for healthcare organizations by consolidating multiple vendor relationships into a single partnership. HRS patrons can expect access to advanced diabetes management tools, including continuous glucose monitoring systems, through an integrated interface.

Commitment to Quality Care

HRS emphasizes its commitment to expanding remote patient care capabilities tailored to evolving healthcare landscapes. CEO Jason Comer stated, “With the recent introduction of PatientFirst Pathways and our foray into Chronic Care Management, the addition of Rimidi strengthens our commitment to delivering comprehensive care.” Relying on collaborations, HRS aims to enhance patient experience while improving clinical outcomes.

In parallel, Dr. Lucienne Ide, the founder of Rimidi and now Chief Medical Officer at HRS, remarked on the shared vision of exceptional patient care that brought the two companies together. By incorporating Rimidi's proven methodologies in chronic disease management, the collaboration intends to extend HRS’s reach, thus making a more significant impact on patient outcomes.

Measurable Impact and Future Integrations

Rimidi's innovative platform generates tangible improvements in clinical outcomes and patient engagement. For example, one of its healthcare partners reportedly achieved a remarkable 2.8% drop in hemoglobin A1c levels among patients with type 2 diabetes, alongside reduced hospitalization rates. Coupled with its advanced continuous glucose monitoring (CGM) integration, Rimidi is well-equipped to enhance clinical workflows and elevate patient care.

The acquisition also bolsters HRS's already strong electronic medical records (EMR) integration capabilities. Current HRS clients can anticipate bolstered diabetes and clinical management functionalities without disruption to their existing patient programs. As integration unfolds throughout the year, HRS plans a seamless transition to unify services and support.

Conclusion

In summary, the acquisition of Rimidi by Health Recovery Solutions marks an essential advancement in remote patient care, combining the strengths of both entities to address chronic disease management more effectively. With their shared goals and commitment to quality, the collaboration is poised to provide innovative solutions that continue to push the boundaries of healthcare delivery. To explore more about HRS and its extensive services, please visit healthrecoverysolutions.com.